Redd&Whyte Appoints New UK Sales Manager
News Feb 21, 2013
Redd&Whyte today announced that it is strengthening its UK presence with the appointment of Sarah Chaudhry as its new UK sales manager. Sarah comes with specialist knowledge of life science laboratory equipment, making her well placed to support Redd&Whyte’s high quality range of Preddator low-volume microplate dispensers throughout the UK.
Sarah has over 12 years’ experience in sales management within major life science equipment companies including Elga Process Water and Sartorius where she supported a range of laboratory systems. Sarah’s commercial expertise is underpinned by a degree in Biomedical Sciences from Sheffield Hallam University. This provides Sarah with extensive knowledge of life science research and automated laboratory equipment to draw from, which she will use to offer advice and support on Redd&Whyte’s Preddator low-volume dispensers range.
Sarah Chaudhry, Redd&Whyte’s UK Sales Manager commented: “I am very pleased to be working for such an innovative UK company and the four channel Preddator system is a very exciting new development. I am looking forward to meeting scientists and showing them how Preddator’s unique dispense head design will help them to accurately and continuously dispense low-volumes and to explaining how it will benefit them by generating consistent assay results, while making substantial savings on reagents and operating costs.”
Roger Poole, Managing Director of Redd&Whyte continued: “We want to develop our UK presence with the Preddator so are delighted to facilitate this by adding a new UK sales manager to our team. Sarah’s specialist approach to supporting laboratory equipment, we believe will allow us to enhance our reputation for delivering unrivalled low-volume dispensing performance to all our existing and potential UK clients.”
Kidney Cancer Driver Could Lead to New Treatment StrategyNews
Scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change can lead to an overabundance of blood vessels, which help feed nutrients to the tumors. Their latest finding shows a potential new cancer-driving pathway.READ MORE
Targeting Headaches and Tumors with Nano-SubmarinesNews
Scientists have developed a new method to enable miniature drug-filled nanocarriers to dock on to immune cells, which in turn attack tumors. In the future, this may lead to targeted treatment that can largely eliminate damage to healthy tissue.READ MORE
CRISPR Screening Reveals Sickle Cell Disease TargetNews
A key signaling protein, known as heme-regulated inhibitor (HRI), has been identified as a potential therapeutic target for the development of drugs to treat sickle cell disease, using a CRISPR screening approach.READ MORE